SGP SpyGlass Pharma, Inc.

NASDAQ
$32.24

SpyGlass Pharma, Inc. (SGP) is expected to report earnings on February 10, 2027, after the market close. The consensus earnings estimate is a loss of $0.77 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.6% since its last earnings release on November 11, 2026.

SpyGlass Pharma Missed Consensus Estimates
Wednesday, November 11, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 10
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.77)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $32.49

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About SpyGlass Pharma, Inc.

Schering-Plough Corporation and its subsidiaries are engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. The company operates primarily in the prescription pharmaceutical marketplace. However, where appropriate, the company has sought regulatory approval to switch prescription products to over-the-counter status as a means of extending a product's life cycle.

Sector

Healthcare

Industry

Drug Delivery

Charts powered in part by Lightweight Charts™ by TradingView.